Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
High immunity cows soon available
New technology breakthrough identifies level of immunity

Sires with a higher natural level of disease resistance will soon be available for farmers to buy, thanks to the latest technology.

Cattle genetics suppliers, Semex, are to sell sires identified as having high immunity - a trait that can be passed on to their offspring in the same way as other inherited traits - under a new brand, immunity+.

Research led by Dr Bonnie Mallard, of the University of Guelph, Canada, found that cows with High Immune Response (HIR) are two to four times less likely to contract diseases than those cows with Low Immune Response (LIR).

The HIR technology identified cows with levels of immune response to diseases such as mastitis, metritis, ketosis, retained placenta and Johne's disease. Those cows with high immunity have a 25 per cent chance of passing the trait on to their offspring.

The company says the new technology "marks a significant breakthrough in improving disease resistance in cattle which will reduce the use of remedial medication".

Managing Director Gordon Miller added: "Trials have shown that using these high immunity sires can significantly reduce the percentage of disease in a herd, which we estimate will be worth about £50 per cow."

HIR testing takes place over two weeks, involving blood samples and skin thickness tests, and the animals are immunised in a similar way to a vaccination that stimulates the immune system.

Sires only need to be tested once in their lifetime to determine genetic immunity levels.

Due to the amount of money invested into the research, the test will be unique to Semex for the next ten years. The first two Immunity+ sires to be marketed are R-E-W Seaver and Charpentier LFG Spectrum. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.